Respiratory Syncytial Virus (RSV) Vaccine: AREXVY Vaccine by GSK
Selected Check-up Services
Comprehensive Medical Check-up Package
Pre-conception and Gynaecological Examination
Single Check-up
Tumor and Genetic Testing
Service Description
Respiratory Syncytial Virus (RSV)is a common and highly contagious virus that can cause severe symptoms and complications, particularly among individuals aged 60 and above, who are more at risk of needing hospital care.According to global research conducted in industrialized countries for individuals aged 60 and above, RSV caused in 2019:
5.2 million cases of acute respiratory infections
470,000 people required hospitalization
33,000 deaths occurring within hospitals annually
AREXVY vaccine combine RSVPreF3 antigen and AS01Eadjuvant system. This vaccine is designed to induce rapid and long-lasting humoral and cellular immune responses, providing protection for seniors. Suitable for individuals aged 60 and above, it effectively prevents lower respiratory tract diseases caused by Respiratory Syncytial Virus (RSV).
Excellent prevention efficacy for individuals aged 60 and above:
Provides 82.6% effectiveness in preventing lower respiratory tract diseases caused by RSV.
Among individuals with at least 1 high-risk complications^, offers 94.6% effectiveness in preventing lower respiratory tract diseases caused by RSV.
Price: $2,700 / 1 dose
Check-up Items and Categories
Register Now
資料已提交, 謝謝
Errors here
*Required
For same day reservation, please call or message us on WhatsApp.
Terms and Conditions:
1. The above item is only applicable for members of EC Healthcare aged 18 or above.
2. The item can only be used once per individual; it cannot be exchanged for cash and other forms of goods and services.
3. Valid identification documents must be presented for registration prior to the treatment.
4. Customers should be aware of and agree to the treatment and its contents before receiving the treatment.
5. The Company reserves the right to withdraw, change, add or alter these terms and conditions without prior notice.
6. In case of dispute, the decision of EC Healthcare shall be final.
Can AREXVY vaccine prevent infections from Respiratory Syncytial Virus (RSV) types A and B?
Absolutely! AREXVY vaccine has an efficacy of over 80% in preventing both RSV types A and B.
Can AREXVY vaccine be administered concurrently with seasonal influenza vaccine?
Yes, it can!
Is AREXVY vaccine safe?
AREXVY vaccine is an FDA-approved vaccine and is authorised for use by the European Medicines Agency. It has demonstrated good tolerability and an acceptable safety profile.
